How useful is spirometry during and following exacerbations of chronic obstructive pulmonary disease?

Not Applicable

• Conditions: COPD exacerbations; Respiratory - Chronic obstructive pulmonary disease

• Registration Number: ACTRN12610000745044
• Lead Sponsor: GlaxoSmithKline (GSK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-09-07
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

current/ex smokers - 10 year pack history
hospital admission diagnosis of COPD exacerbation

Exclusion Criteria

Non-english speaking
Confused/comatose/unable to follow instructions
Requiring mechanical ventilation/intensive care

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ength of hopsital stay, determined by admission and discharge time[at discharge];Change in initial diagnosis compared to discharge (final)diagnosis, determined from admission and discharge notes[admission and discharge];treatment success or failure, success being discharge without futher complications and failure being need for mechanical ventilation and/or intensive care[at discharge or if treatment fails, at onset of mechanical ventilation/intensive care]

Secondary Outcome Measures

Name	Time	Method
differences in management, e.g. medications and referrals. between test and control groups, determined from medical records[at discharge and 4 week follow-up]